Krónikus vesebetegség: vizsgálatok itt: Mexikó
23 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Chihuahua City, Cuauhtémoc, D.F, Durango, Guadalajara, Mazatlán, Mérida, San Luis Potosí City, Veracruz, Zapopan
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León, Mérida, Mexicali, México, Mexico City, Monterrey, Tijuana, Veracruz, Villahermosa
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Veracruz
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - No phaseTaking peopleContinuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
- Where
- Mexico City
- Életkor
- 40 év to 70 év
- People
- 110
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT06069518 - No phaseNot yet taking people in MexikóA Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 800
- Run by
- Bayer
See details and how to joinNCT07841015 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Benito Juárez, Querétaro
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Aguascalientes, México D.F., México, D.F., Monterrey, Veracruz
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - 3. fázisTaking peopleA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Benito Juárez, Culiacán, Durango, Ecatepec de Morelos, Estado de México, México, Mexico City, Tuxpan, Veracruz, Villahermosa, Xalapa
- Életkor
- 18 év to 99 év
- People
- 2800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Mexico City, Monterrey
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Iztapalapa, León, México, Mexico City
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Chihuahua City, Culiacán, Mazatlán, Mérida, Monterrey, Zapopan
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Chihuahua City, Cuernavaca, Guadalajara, Mexico City, Monterrey, Zapopan
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - No phaseTaking peopleThe FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion
- Where
- Monterrey
- Életkor
- 18 év and over
- People
- 70
- Run by
- Universidad Autonoma de Nuevo Leon
See details and how to joinNCT07705269 - No phaseTaking peopleProbiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients
- Where
- Monterrey
- Életkor
- 18 év and over
- People
- 60
- Run by
- Hospital Universitario Dr. Jose E. Gonzalez
See details and how to joinNCT07694791 - 1/2. fázisTaking peopleIntradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.
- Where
- Colima
- Életkor
- 18 év and over
- People
- 48
- Run by
- Pedro Julian Flores Moreno
See details and how to joinNCT07666815 - 4. fázisTaking peopleEfficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
- Where
- Aguascalientes
- Életkor
- 14 év to 18 év
- People
- 200
- Run by
- Centenario Hospital Miguel Hidalgo
See details and how to joinNCT07405216 - 3. fázisTaking peopleA Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Where
- Cuernavaca, Guadalajara, Mexico City
- Életkor
- 2 év to 17 év
- People
- 129 worldwide
- Run by
- AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00 - No phaseNot yet taking people in MexikóExpanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 15
- Run by
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
See details and how to joinNCT07348536 - No phaseNot yet taking people in MexikóMultimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)
- Where
- Aguascalientes
- Életkor
- 14 év to 35 év
- People
- 200
- Run by
- Centenario Hospital Miguel Hidalgo
See details and how to joinNCT07483697 - 4. fázisNot yet taking people in MexikóLow-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)
- Where
- Guadalajara
- Életkor
- 18 év and over
- People
- 54
- Run by
- Hospital Civil de Guadalajara
See details and how to joinNCT07404345 - No phaseCsak meghívásosType 2 Diabetes and Associated Factors in Mexico
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT07248891 - No phaseCsak meghívásosIntradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients
- Where
- León
- Életkor
- 18 év to 50 év
- People
- 50
- Run by
- Universidad de Guanajuato
See details and how to joinNCT06788054 - No phaseTaking peopleEffect of a Specialized Oral Supplement on Nutritional Status and Quality of Life in Non-dialysis CKD
- Where
- Guadalajara
- Életkor
- 18 év to 90 év
- People
- 50
- Run by
- NIN Institute
See details and how to joinNCT06576479